Company: HROW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000925
Chunk: 905

Company: HARROW, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 5
Chunk 905
---
 
  
    TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 
    $388,971,000  
    $312,164,000 

The accompanying notes are an integral part of these
consolidated financial statements

F-5

HARROW, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

    2024  
    2023 

    For the Years Ended 

    December 31, 

    2024  
    2023 
  
    Revenues: 

    Product sales, net 
    $198,619,000  
    $117,447,000 
  
    Other revenues 
     995,000  
     12,746,000 
  
    Total revenues 
     199,614,000  
     130,193,000 
  
    Cost of sales 
     (49,245,000) 
     (39,640,000)
  
    Gross profit 
     150,369,000  
     90,553,000 
  
    Operating expenses: 

    Selling, general and administrative 
     129,064,000  
     83,090,000 
  
    Research and development 
     12,230,000  
     6,652,000 
  
    Impairment of long-lived assets 
     253,000  
     380,000 
  
    Total operating expenses 
     141,547,000  
     90,122,000 
  
    Income from operations 
     8,822,000  
     431,000 
  
    Other (expense) income: 

    Interest expense, net 
     (22,786,000) 
     (21,324,000)
  
    Investment (loss) gain from Eton Pharmaceuticals 
     (3,171,000) 
     3,092,000 
  
    Loss on extinguishment of debt 
     -  
     (5,465,000)
  
    Other expense, net 
     (185,000) 
     (444,000)
  
    Total other expense, net 
     (26,142,000) 
     (24,141,000)
  
    Loss before income taxes 
     (17,320,000) 
     (23,710,000)